2000
DOI: 10.1038/sj.onc.1203425
|View full text |Cite
|
Sign up to set email alerts
|

Genetic variants of CYP19 (aromatase) and breast cancer risk

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

6
122
4
2

Year Published

2003
2003
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 155 publications
(134 citation statements)
references
References 17 publications
6
122
4
2
Order By: Relevance
“…It is unclear whether Hap3 functionally affects CIN risk. However, MTHFR A1298C is a functional variant and 5 0 flank polymorphism may have functional significance by affecting mRNA stability or regulation of translation [33,34].…”
Section: Discussionmentioning
confidence: 99%
“…It is unclear whether Hap3 functionally affects CIN risk. However, MTHFR A1298C is a functional variant and 5 0 flank polymorphism may have functional significance by affecting mRNA stability or regulation of translation [33,34].…”
Section: Discussionmentioning
confidence: 99%
“…Block 4 SNPs were located in the coding region and 3 0 UTR, which may have functional significance by affecting mRNA stability or regulation of translation termination. 23 These SNPs may also be in strong LD with other functional variants elsewhere in the block. Block 3 SNPs were between the promoter I.f and I.2, which were expressed in brain and placenta, respectively.…”
Section: Discussionmentioning
confidence: 99%
“…The variant T allele was previously suggested to be associated with a high estrogen profile because it was correlated with tumor aromatase mRNA levels. The variant T allele is associated with alternative promoter use (Somner et al 2004), and Kristensen et al (2000) found that it was more frequent in breast cancer cases than in their controls. Other studies have found no association between the 1531C>T polymorphism and breast cancer risk, and the present study found that the CYP19 1531C>T polymorphism is not associated with the risk of endometriosis.…”
Section: Discussionmentioning
confidence: 99%
“…The CYP19 gene has several polymorphisms: a [TTTA]n tetranucleotide repeat polymorphism in intron 4 (Healey et al 2000;Kristensen et al 2000), a 115T>C polymorphism in exon 2 (Trp39Arg) (Miyoshi et al 2000), a silent 240A>G polymorphism at codon 80 in exon 3 (Siegelmann-Danieli and Buetow 1999), a 790C>T polymorphism in exon 8 (Arg264Cys) (Toda et al 1990;Kristensen et al 2000;Lee et al 2003), and a 1531C>T polymorphism in the 3¢ untranslated region of exon 10 (Sourdaine et al 1994). CYP19 gene polymorphisms are reportedly associated with estrogen-dependent diseases, such as uterine myoma, endometriosis, breast cancer, and endometrial cancer (Hirose et al 2004;Bulun et al 2005;Paynter et al 2005).…”
Section: Introductionmentioning
confidence: 99%